Optimum doses of irinotecan (multiple letters) [9]

C. Erlichman; R. M. Goldberg; H. C. Pitot; M. J. O'Connell; D. Cunningham

doi:10.1016/S0140-6736(05)75197-7

Optimum doses of irinotecan (multiple letters) [9]

C. Erlichman, R. M. Goldberg, H. C. Pitot, M. J. O'Connell, D. Cunningham

Medical Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1275-1276
Number of pages	2
Journal	Lancet
Volume	353
Issue number	9160
DOIs	https://doi.org/10.1016/S0140-6736(05)75197-7
State	Published - Apr 10 1999

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(05)75197-7

Cite this

@article{9d225d43def14b53bb9cc25d4170557a,

title = "Optimum doses of irinotecan (multiple letters) [9]",

author = "C. Erlichman and Goldberg, {R. M.} and Pitot, {H. C.} and O'Connell, {M. J.} and D. Cunningham",

year = "1999",

month = apr,

day = "10",

doi = "10.1016/S0140-6736(05)75197-7",

language = "English (US)",

volume = "353",

pages = "1275--1276",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9160",

}

TY - JOUR

T1 - Optimum doses of irinotecan (multiple letters) [9]

AU - Erlichman, C.

AU - Goldberg, R. M.

AU - Pitot, H. C.

AU - O'Connell, M. J.

AU - Cunningham, D.

PY - 1999/4/10

Y1 - 1999/4/10

UR - http://www.scopus.com/inward/record.url?scp=0033541570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033541570&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(05)75197-7

DO - 10.1016/S0140-6736(05)75197-7

M3 - Letter

C2 - 10217115

AN - SCOPUS:0033541570

SN - 0140-6736

VL - 353

SP - 1275

EP - 1276

JO - Lancet

JF - Lancet

IS - 9160

ER -

Optimum doses of irinotecan (multiple letters) [9]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this